The pandemic led to a severe recession, followed by a strong recovery. This briefing examines different aspects of the economic impact of the pandemic to date and outlines the key issues for the economic outlook.
Obesity is a physical condition in which a person is very overweight, with a lot of body fat.
The prevalence of obesity in the UK has long been an issue for the government and the National Health Service (NHS). Almost two-thirds of adults in England are living with excess weight for their height, with similar figures in Scotland, Wales and Northern Ireland.
A range of factors, including obesity, have been identified as increasing a person’s risk of becoming seriously ill after contracting Covid-19.
Public Health England’s (PHE) July 2020 research report into Excess Weight and COVID-19 looked at available evidence up to July. It found that excess weight is associated with increased risk of being hospitalised with Covid-19, being subject to advanced treatment e.g. mechanical ventilation, and death from Covid-19. PHE report that the risks appear to increase at higher BMI (body mass index) levels, even after adjusting for other factors like socio-economic status. BMI is more strongly correlated with testing positive for COVID-19 among BAME ethnic groups than among White ethnic groups.
The current evidence does not suggest that having excess weight increases people’s chances of contracting Covid-19. However, the data does show that obese people are significantly more likely to become seriously ill and be admitted to intensive care with Covid-19 compared to those with a healthy BMI.
One study found that for people with a BMI of 35 to 40, risk of death from Covid-19 increases by 40% and with a BMI over 40 by 90%, compared to those not living with obesity. Other data found that in intensive care units, 7.9% of critically ill patients with Covid-19 had a BMI over 40 compared with 2.9% of the general population.
PHE emphasises that these findings should be interpreted with some caution. Most of the research reports that PHE describe look at data on hospitalised patients with proven Covid-19 infection. As such, there may be differences among other groups, such as those who were not hospitalised. As with many questions around the pandemic, our knowledge is not complete.
Before the pandemic, the Government was working on a range of measures to reduce obesity, these are discussed in the Commons Library Briefing, Obesity (CBP 9049, 9 Nov 2020). In light of the pandemic, the Government has made a number of announcements outlining additional work on obesity; these are linked below.
The Government has said:
‘Tackling obesity: empowering adults and children to live healthier lives’ [the Government’s July 2020 obesity strategy] demonstrates an overarching campaign to reduce obesity, takes forward actions from previous chapters of the childhood obesity plan and sets out measures to get the nation fit and healthy, protect against COVID-19 and protect the National Health Service.
A number of other bodies have reported on the association between obesity and negative Covid-19 outcomes; these are also linked below.
House of Commons Library
Obesity, Commons Library Briefing, CBP 9049, 9 November 2020
Obesity statistics, Commons Library Briefing, CBP 3336, 6 August 2019
Health inequalities: Income deprivation and north/south divides, Commons Library Insight, 22 January 2019
Social prescribing, Commons Library Briefing, CBP 8997, 2 September 2020
Coronavirus: health and social care key issues and sources, Commons Library Briefing, CBP 8887, 30 June 2020
The House of Commons Library coronavirus research hub contains a range of other coronavirus research briefings.
House of Lords Library
Tackling childhood obesity: What is the strategy?, House of Lords Library, 26 August 2020
Press releases and guidance statements
National Institute for Health and Care Excellence (NICE), ‘NICE’s support for rebuilding capacity in non-COVID health services’, 15 September 2020
European Association for the Study of Obesity (EASO), ‘Position statement on the global COVID-19 pandemic’, May 2020
EASO, ‘Obesity and COVID-19: The two sides of the coin’, October 2020
PHE, ‘Supporting weight management services during the COVID-19 pandemic’, 7 September 2020
Local Government Association, ‘Social care and obesity’, August 2020
Obesity Action Scotland/Royal College of Physicians and Surgeons of Glasgow, ‘Obesity and COVID-19’, July/August 2020
Public Health Wales, ‘International horizon scanning and learning to inform Wales’ COVID-19 public health response and recovery’, 6 August 2020
Public Health Agency [Northern Ireland], ‘Health intelligence: COVID-19 evidence and guidance overview- obesity, physical activity and nutrition’, 29 July 2020
PHE, ‘Excess weight and COVID-19: Insights from new evidence’, 24 July 2020
PHE, ‘COVID-19: The secondary harms excess weight and COVID-19’, 20 July 2020
PHE, Weight management services during COVID-19: phase 1 insights, 20 September 2020
A wide range of research has been published since the beginning of the pandemic on the links between obesity and Covid-19, including:
Moussa et al, ‘Impact of COVID-19 on obesity management services in the UK (The COMS-UK study)’, Obesity Surgery, 2020
Rubino et al, ‘Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery’, The Lancet Diabetes & Endocrinology, May 2020
British Medical Journal, ‘Covid-19: England’s obesity strategy will fail without tackling social factors, warn doctors’, July 2020
 Public Health England, Excess Weight and COVID-19, Insights from new evidence, 24 Jul 2020
 Body mass index (BMI) is a measure that uses a person’s height and weight to determine whether their weight is healthy. The BMI calculation divides an adult’s weight in kilograms by their height in metres squared. An NHS webpage provides further information: NHS, What is the body mass index (BMI), (accessed 9 Nov 2020)
 Black, Asian and Minority Ethnic
 BMI below 18.5 is in the underweight range, between 18.5-24.9 is in the healthy range, between 25 and 29.9 is in the overweight range and between 30 and 29.9 is in the obese range. See NHS, What is the body mass index (BMI), (accessed 9 Nov 2020)
A note on the main measures and impact of the Corporate Insolvency and Governance Act 2020. The Act introduced permanent measures to update the UK insolvency regime, and temporary measures to help businesses during the pandemic.
This briefing provides an overview of the regulatory concerns associated with batches of the Vaxzevria (previously called AstraZeneca) vaccine that were manufactured in India and the associated travel issues.